Lobectomy versus sub-lobectomy for clinical stage IA (≤2cm) lung squamous cell carcinoma with tumor spread through air spaces: A multi-center retrospective study.

Hanbo Pan, Hang Chen, Zhen Ge, Yu Tian, Weicheng Kong, Wanyu Li, Junwei Ning, Zhiyuan Bao, Zhizhuo Dai, Zhongjie Chen, Difan Zhang, Liang Fang, Min Zheng, Guomo Ruan, Hui Wang, Ming Zhang, Hui Yin, Jia Huang, Chengwei Zhou, Guodong Xu, Qingquan Luo
{"title":"Lobectomy versus sub-lobectomy for clinical stage IA (≤2cm) lung squamous cell carcinoma with tumor spread through air spaces: A multi-center retrospective study.","authors":"Hanbo Pan, Hang Chen, Zhen Ge, Yu Tian, Weicheng Kong, Wanyu Li, Junwei Ning, Zhiyuan Bao, Zhizhuo Dai, Zhongjie Chen, Difan Zhang, Liang Fang, Min Zheng, Guomo Ruan, Hui Wang, Ming Zhang, Hui Yin, Jia Huang, Chengwei Zhou, Guodong Xu, Qingquan Luo","doi":"10.1093/ejcts/ezaf224","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The efficacy of sub-lobectomy for clinical IA (tumors ≤2cm) lung squamous cell carcinoma with tumor spread through air spaces remains unknown. This study compares long-term survival outcomes between sub-lobectomy and lobectomy, aiming to offer pivotal evidence for optimizing resection strategies for clinical IA spread through air spaces-positive squamous cell carcinoma patients.</p><p><strong>Methods: </strong>Consecutive clinical IA spread through air spaces-positive squamous cell carcinoma patients undergoing surgery between 2010 and 2020 at seven high-volume institutions across five Chinese cities were retrospectively reviewed. The primary endpoint was overall survival, and the secondary endpoint was recurrence-free survival. Propensity-score matching was employed to mitigate selection bias.</p><p><strong>Results: </strong>A total of 870 patients were included, and propensity-score matching yielded 476 and 238 cases in the Lobe and Sub-lobe groups, respectively. Over an estimated median follow-up of 6.51 years, lobectomy significantly improved overall survival [hazard ratio[95% confidence interval]=0.598[0.447-0.761],P<0.001)] and recurrence-free survival (hazard ratio[95% confidence interval]=0.572[0.449-0.733],P<0.001), and reduced postoperative mortality (30.7% vs. 40.3%,P=0.010) and recurrence (39.3% vs. 55.0%,P<0.001) incidences compared to sub-lobectomy. Further subgroup analysis revealed that lobectomy improved survival outcomes over sub-lobectomy in younger (age <70 years) and clinical IA2 sub-cohorts, while the two approaches yielded comparable survival outcomes for elderly (age ≥70 years) and clinical IA1 sub-cohorts.</p><p><strong>Conclusions: </strong>Lobectomy improved survival outcomes over sub-lobectomy for clinical IA spread through air spaces-positive squamous cell carcinoma and thus might be preferred for clinical IA squamous cell carcinoma patients with highly suspected spread through air spaces. The prognostic benefits of lobectomy may be discriminated by age and clinical stage.</p>","PeriodicalId":520617,"journal":{"name":"European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ejcts/ezaf224","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: The efficacy of sub-lobectomy for clinical IA (tumors ≤2cm) lung squamous cell carcinoma with tumor spread through air spaces remains unknown. This study compares long-term survival outcomes between sub-lobectomy and lobectomy, aiming to offer pivotal evidence for optimizing resection strategies for clinical IA spread through air spaces-positive squamous cell carcinoma patients.

Methods: Consecutive clinical IA spread through air spaces-positive squamous cell carcinoma patients undergoing surgery between 2010 and 2020 at seven high-volume institutions across five Chinese cities were retrospectively reviewed. The primary endpoint was overall survival, and the secondary endpoint was recurrence-free survival. Propensity-score matching was employed to mitigate selection bias.

Results: A total of 870 patients were included, and propensity-score matching yielded 476 and 238 cases in the Lobe and Sub-lobe groups, respectively. Over an estimated median follow-up of 6.51 years, lobectomy significantly improved overall survival [hazard ratio[95% confidence interval]=0.598[0.447-0.761],P<0.001)] and recurrence-free survival (hazard ratio[95% confidence interval]=0.572[0.449-0.733],P<0.001), and reduced postoperative mortality (30.7% vs. 40.3%,P=0.010) and recurrence (39.3% vs. 55.0%,P<0.001) incidences compared to sub-lobectomy. Further subgroup analysis revealed that lobectomy improved survival outcomes over sub-lobectomy in younger (age <70 years) and clinical IA2 sub-cohorts, while the two approaches yielded comparable survival outcomes for elderly (age ≥70 years) and clinical IA1 sub-cohorts.

Conclusions: Lobectomy improved survival outcomes over sub-lobectomy for clinical IA spread through air spaces-positive squamous cell carcinoma and thus might be preferred for clinical IA squamous cell carcinoma patients with highly suspected spread through air spaces. The prognostic benefits of lobectomy may be discriminated by age and clinical stage.

肺叶切除术与亚肺叶切除术治疗临床期(≤2cm)肺鳞状细胞癌伴肺间隙扩散的多中心回顾性研究
目的:临床IA(肿瘤≤2cm)肺鳞状细胞癌经气腔扩散行肺叶下切除术的疗效尚不明确。本研究比较了肺叶亚切除术和肺叶切除术的长期生存结果,旨在为优化临床IA经空气间隙阳性的鳞状细胞癌患者的切除策略提供关键证据。方法:回顾性分析2010年至2020年在中国5个城市的7家高容量机构接受手术的连续临床IA通过空气间隙阳性的鳞状细胞癌患者。主要终点是总生存期,次要终点是无复发生存期。采用倾向分数匹配来减轻选择偏差。结果:共纳入870例患者,肺叶组和亚肺叶组的倾向评分匹配分别为476例和238例。在估计的中位随访6.51年期间,肺叶切除术显著提高了总生存率[风险比[95%置信区间]=0.598[0.447-0.761]。结论:肺叶切除术比亚肺叶切除术改善了临床IA经空气间隙扩散的鳞状细胞癌患者的生存结果,因此可能更适合临床IA经空气间隙扩散的鳞状细胞癌患者。肺叶切除术的预后益处可根据年龄和临床分期来区分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信